LMN-NKA acetate

Item number	Size	Datasheet	Manual	SDS	Delivery time	Price
TGM-T76426L-1mg	1 mg	-	-	-	7 - 10 business days*	183.00€
TGM-T76426L-5mg	5 mg	-	-	-	7 - 10 business days*	456.00€
TGM-T76426L-10mg	10 mg	-	-	-	7 - 10 business days*	654.00€
TGM-T76426L-25mg	25 mg	-	-	-	7 - 10 business days*	1,023.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: LMN-NKA acetate is a modified Neurokinin A (4-10) and selective NK2R (Neurokinin 2... more

Close menu

Product information "LMN-NKA acetate"

Description: LMN-NKA acetate is a modified Neurokinin A (4-10) and selective NK2R (Neurokinin 2 receptor) agonist that induces bladder contraction and urination/defecation in rats, and can be used for studying smooth muscle contraction. Target: Neurokinin receptor. Smiles: OC(C[C@H](N)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](C(C)C)C(NCC(N(C)[C@@H](CC(C)C)C(N[C@H](C(O)=O)CCCC)=O)=O)=O)=O)CC1=CC=CC=C1)=O)=O)=O.CC(O)=O. References: Rupniak NMJ, et al. [Lys5,MeLeu9,Nle10]-NKA(4-10) Elicits NK2 Receptor-Mediated Micturition and Defecation, and NK1 Receptor-Mediated Emesis and Hypotension, in Conscious Dogs. J Pharmacol Exp Ther. 2018 Jul,366(1):136-144.

Keywords:	LMN-NKA acetate(149270-28-0 Free base) , [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) acetate
Supplier:	TargetMol
Supplier-Nr:	T76426L

Properties

Conjugate:	No
MW:	865.03 D
Formula:	C41H68N8O12

Database Information

Handling & Safety

Storage:	+4°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "LMN-NKA acetate"

Write a review